WEST JEFFERSON, OHIO / ACCESS Newswire / January 30, 2025 / AmplifyBio, a leading preclinical CRO and CDMO played a pivotal ...

VectorBuilder's partner, Ucello, announced that its CD19-targeting umbilical cord blood-derived allogeneic CAR-T cell therapy ...

The Howard Hughes Medical Institute has named Fred Hutch Cancer Center postdoctoral researcher Grant King, PhD, a Hanna H.

IMNN READ THE FULL IMNN RESEARCH REPORT Business Update Gearing Up to Initiate Phase 3 Ovarian Cancer Trial Imunon, Inc. (NASDAQ:IMNN) is continuing preparations to conduct a Phase 3 clinical trial of ...

In this valuable manuscript, authors ablate cerebellar oligodendrocytes during postnatal development and show that synchrony of calcium transients in Purkinje neurons and behaviours are affected even ...

Isomerase has today announced the release of its Isochassis platform, a comprehensive collection of proprietary engineered microbial hosts designed to meet industrial recombinant protein and biologics ...

Updated 2025 market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

Azenta, Inc. shares have surged over 30% since Nov 2024 due to S&P 600 inclusion and an analyst upgrade, despite somewhat ...

Researchers made a “huge breakthrough” when they did an experiment “purely out of curiosity” which solves “a decades-long ...

Right now, we actually have no plans to move forward; it’s ready to go if we decide,” company spokeswoman said.

An international collaboration has achieved an important breakthrough in understanding the genetic mechanisms that allow ...